Literature Database for Discrete Element Method Simulation Available Online - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Literature Database for Discrete Element Method Simulation Available Online


DEM Solutions made available an extensive, searchable, online library of abstracts of peer-reviewed papers on the development and application of discrete element method (DEM) simulation for modeling bulk particle processes, the company announced in a press release.

The resource has been available to DEM Solutions' customers and academic users and is now publicly available. “With growing interest in deploying DEM simulation across many of the manufacturing and process industries, we wanted to open up access to non-customers as well in order to foster innovation and new application areas,” said John Favier, PhD, CEO of DEM Solutions, in the press release.

The DEM Literature Database currently includes abstracts of over 3000 papers and is searchable by title, author, keywords, publisher, and year of publication, including links to publication sources where the full-text papers can be obtained. The database includes papers published from 2001 through early 2013 and will be updated regularly as new papers are made available.

“We want to make it much easier for those in commercial R&D and academic research to find out about the latest DEM developments, as well as to locate previous studies using similar methodology or addressing the same engineering challenges,” said Favier. “Visitors can follow the work of thousands of DEM researchers over the last decade or explore the progression of DEM deployment within an industry vertical or engineering discipline.”

DEM Solutions commented on DEM simulation in the pharmaceutical industry in a recent Pharmaceutical Technology article, “Developments in Pharmaceutical Process Modeling.”

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing

Click here